IntrinsicIntrinsic

Addus HomeCare Corp

ADUS
🏢 Services-Home Health Care Services

Business Operations Summary

Addus HomeCare Corporation operates in the home care services industry, providing personal care, hospice, and home health services primarily to "dual eligible" consumers who qualify for both Medicare and Medicaid benefits . The company's business model focuses on delivering care in the home, which is generally more cost-effective than facility-based care and preferred by consumers . This approach aims to reduce chronic and acute care treatment costs by delaying or eliminating the need for more expensive institutional settings and by facilitating early intervention through caregiver observation and reporting of changes in consumer conditions . The industry is characterized by fragmentation, with many small participants and a few larger ones, and is experiencing ongoing consolidation driven by healthcare systems and managed care organizations seeking to narrow their provider networks, alongside increasing regulatory, operating, and technology requirements . As of December 31, 2025, Addus provided services in 23 states through approximately 262 offices, serving about 107,000 discrete consumers .

The company's core business model generates revenue from federal, state, and local government agencies, managed care organizations, commercial insurers, and private individuals . Managed care organizations represent a significant portion of revenue, accounting for 37.0% of total net service revenues in 2025, 34.8% in 2024, and 36.6% in 2023. Revenue recognition varies by segment: personal care revenue is recognized hourly based on authorized hours, hospice revenue is recognized daily based on levels of care, and home health revenue is recognized episodically based on days elapsed during a period of care 10.

The Personal Care segment provides non-medical assistance with activities of daily living, such as bathing, grooming, meal preparation, and transportation, primarily to the elderly, chronically ill, or disabled . This segment also includes staffing services for assisted living facilities, nursing homes, and hospice facilities . For the year ended December 31, 2025, the Personal Care segment generated $1,089,215 thousand in net service revenues, representing 76.6% of total net service revenues . Its gross profit margin was 27.9% . A significant portion of this segment's revenue, 50.8% , came from state, local, and other governmental programs in 2025, with the Illinois Department on Aging alone accounting for 18.1% of the company's total net service revenues.

The Hospice segment offers physical, emotional, and spiritual care for terminally ill individuals with a life expectancy of six months or less, along with family support services like palliative nursing care, social work, and bereavement counseling . For the year ended December 31, 2025, the Hospice segment reported net service revenues of $262,542 thousand , contributing 18.5% of total net service revenues . This segment achieved a gross profit margin of 48.7% . Medicare was the primary payor for hospice services, accounting for 93.1% of the segment's net service revenues in 2025.

The Home Health segment provides primarily medical services, including skilled nursing and various therapies (physical, occupational, speech), typically on a short-term, intermittent, or episodic basis to patients recovering from illness or injury . For the year ended December 31, 2025, the Home Health segment generated $70,773 thousand in net service revenues, representing 5.0% of total net service revenues . Its gross profit margin stood at 41.8% . Medicare was also the largest payor for home health services, contributing 67.4% of the segment's net service revenues in 2025.

For the fiscal year ended December 31, 2025, Addus HomeCare Corporation reported total net service revenues of $1,422,530 thousand . Gross profit was $461,874 thousand , resulting in a gross margin of 32.5% . Operating income reached $138,615 thousand , representing an operating margin of 9.7% . Net income for the period was $95,910 thousand . Basic net income per share was $5.31 , and diluted net income per share was $5.22 . As of December 31, 2025, the company had cash balances of $81,617 thousand and total long-term debt, net of debt issuance costs, of $120,959 thousand . Free cash flow is not explicitly provided in the summary financial data.

Comparing 2025 to 2024, total net service revenues increased by 23.2% from $1,154,599 thousand to $1,422,530 thousand . This growth was driven by increases across all segments: Personal Care revenues rose by $232,634 thousand (27.2% ), Hospice revenues increased by $34,351 thousand (15.1% ), and Home Health revenues saw a modest increase of $946 thousand (1.4% ). The overall gross profit margin remained consistent at 32.5% in both periods. However, the Personal Care segment's gross margin slightly decreased from 28.3% in 2024 to 27.9% in 2025, while the Hospice segment's gross margin improved from 47.0% to 48.7% , and Home Health's gross margin significantly increased from 36.8% to 41.8% . Operating income increased by 35.0% from $102,691 thousand in 2024 to $138,615 thousand in 2025, with the operating margin expanding from 8.9% to 9.7% . Net income grew by 30.3% from $73,598 thousand to $95,910 thousand .

During 2025, Addus completed four acquisitions: Gold Horses, LLC on October 1, 2025, expanding its personal care segment in Texas; Helping Hands Home Care Service, Inc. on August 1, 2025, expanding personal care and entering hospice markets in Pennsylvania; Great Lakes Home Care Unlimited, LLC on March 1, 2025, expanding personal care in Michigan; and its Jacksonville affiliate on January 1, 2025, expanding personal care in Florida . These 2025 acquisitions collectively contributed $11.8 million in net service revenues for the year. The company also divested its New York personal care operations, effective May 20, 2024, for a purchase price of up to $23.0 million in cash, recognizing a gain on divestiture of $3.7 million in 2024.

Business Outlook & Future Growth Drivers

The filing does not provide explicit forward-looking guidance for specific revenue, margin, or EPS figures for the upcoming period.

Addus HomeCare Corporation anticipates continued growth through several strategic initiatives. The company plans to drive organic growth in existing markets by enhancing sales and marketing capabilities, improving business intelligence analytics, recruiting and retaining employees, and investing in technology and operations to boost efficiencies . This organic growth is expected to benefit from increasing demand for home-based services due to the aging U.S. population and a preference for in-home care, a trend potentially heightened by public health concerns associated with institutional settings . The company also intends to selectively open new offices in existing markets where opportunities are identified .

A significant growth vector involves expanding partnerships with managed care organizations. Addus believes its coordinated care model, integration of services into the broader healthcare industry, status as a larger and more experienced provider, and sophisticated technology offerings (including electronic visit records and an outcomes-driven approach) make it attractive to these organizations . The expansion from primarily personal care services into hospice and home health has further diversified its home-based care offerings, increasing its value to managed care partners .

The company also plans to grow through strategic acquisitions, focusing on expanding its presence in current markets and entering new ones, particularly in states with favorable demographics, fiscally sound management, reasonable minimum wage environments, and the potential to become a leading provider . This acquisition strategy aims to support its managed care organization strategy . The company's active pipeline and strong financial position are noted as supporting additional acquisitions .

Operationally, the company expects to benefit from rate increases in certain states. For instance, the Illinois fiscal year 2026 budget includes an increase in hourly rates for in-home care services to $30.80 , effective January 1, 2026, which sustains a minimum wage of $18.75 per hour for direct service workers . Similarly, the Texas fiscal year 2026 budget included an increase in hourly rates to $17.13 for in-home care services, effective September 1, 2025 . However, the company notes that there is no assurance of additional rate increases in Illinois beyond fiscal year 2026 to offset potential minimum wage increases, which could adversely impact financial performance . In the hospice segment, CMS increased hospice payment rates by 2.6% effective October 1, 2025, reflecting a 3.3% market basket increase and a negative 0.7 percentage point productivity adjustment . For home health, CMS estimates Medicare payments to home health agencies will decrease by 1.3% for calendar year 2026, based on a 2.4% payment update percentage (reflecting a 3.2% market basket update reduced by a 0.8 percentage point productivity adjustment ).

Regarding capital allocation, the company plans to retain any earnings to support operations and finance business growth, rather than paying cash dividends in the foreseeable future . Its credit facility restricts dividend payments, allowing distributions up to $10.0 million per annum to Holdings, absent an event of default . The company's primary sources of liquidity are cash on hand, anticipated cash flows from operations, and borrowings under its credit facility . As of December 31, 2025, the company had $517.7 million available for borrowing under its credit facility .

The company explicitly flags several structural headwinds and execution risks. Macroeconomic conditions, including inflationary pressures, elevated interest rates, and challenging labor market conditions, are expected to continue impacting the company's ability to attract and retain caregivers and skilled healthcare staff, potentially leading to increased operating costs . The company may not be able to offset these higher labor costs with sufficient rate increases from government programs and private payors . Furthermore, ongoing uncertainty regarding the federal budget and spending levels, coupled with state budgetary pressures (potentially augmented by the "One Big Beautiful Bill Act" or "OBBBA"), could lead to decreased spending or spending growth for Medicaid programs, impacting reimbursements . The OBBBA is also expected to decrease federal Medicaid spending through changes to eligibility policies and financing mechanisms, including limitations on provider tax arrangements and state directed payment (SDP) arrangements . A CMS final rule in May 2024, effective by mid-2030, will require states to ensure that at least 80% of Medicaid payments for homemaker, home health aide, and personal care services are spent on direct care worker compensation, which could increase labor costs .

Major Risk Factors & Challenges

The company faces material risks including the adverse impact of negative macroeconomic conditions such as inflationary pressures, elevated interest rates, and challenging labor market conditions, which could increase operating costs, particularly wages, and may not be offset by rate increases from government programs and private payors . Regulatory changes, especially those impacting Medicaid funding and administration, pose significant risks, with the "One Big Beautiful Bill Act" (OBBBA) expected to decrease federal Medicaid spending and impose limitations on provider tax and state directed payment arrangements . A CMS final rule, effective by mid-2030, mandates that at least 80% of Medicaid payments for certain HCBS services be spent on direct care worker compensation, potentially increasing labor costs . The company's revenue concentration in a few states, notably Illinois (37.0% of net service revenues in 2025, with 18.1% from the Illinois Department on Aging), New Mexico (13.1% ), and Texas (15.2% ), makes it highly sensitive to regulatory and economic changes in these states . Cybersecurity threats and security breaches could lead to loss of confidential consumer data, remediation expenses, liability under privacy laws, litigation, and reputational damage . The company's growth strategy, reliant on acquisitions and expansion into new geographic regions, carries risks related to integration difficulties, unforeseen liabilities, and the need for additional capital or lender consent, especially if its Total Net Leverage Ratio exceeds 3.75:1.00 (or 4.25:1.00 in certain Material Acquisition circumstances) .

Management Priorities & Sentiments

Management's overall tone emphasizes a commitment to strategic growth through both organic initiatives and targeted acquisitions, while navigating a complex and evolving healthcare regulatory landscape. They highlight the company's model as providing significant value to managed care organizations by offering cost-effective, in-home care that improves consumer outcomes and satisfaction. Management explicitly states that the company plans to retain any earnings to support the operation and growth of the business, and does not intend to pay any dividends on its common stock in the foreseeable future . Key strategic priorities include consistently providing high-quality care, driving organic growth in existing markets by enhancing sales and marketing, business intelligence, and investing in technology and operations for efficiency, and growing through acquisitions in favorable markets to support the managed care organization strategy . Management also notes the importance of attracting and retaining qualified personnel in a challenging labor market, acknowledging potential impacts of increased labor costs and the "80/20" payment adequacy requirement from CMS .

References

  1. [1] Item 1, Business — Overview
  2. [2] Item 1, Business — Overview
  3. [3] Item 1, Business — Overview
  4. [4] Item 1, Business — Our Market and Opportunity
  5. [5] Item 1, Business — Overview
  6. [6] Item 1, Business — Overview
  7. [7] Item 7, MD&A — Overview
  8. [8] Item 7, MD&A — Overview
  9. [9] Item 7, MD&A — Overview [1, 10] Item 7, MD&A — Components of our Statements of Income
  10. [11] Item 1, Business — Personal Care
  11. [12] Item 1, Business — Personal Care
  12. [13] Item 7, MD&A — Results of Operations
  13. [14] Item 7, MD&A — Results of Operations
  14. [15] Item 7, MD&A — Personal Care Segment
  15. [16] Item 7, MD&A — Personal Care Segment
  16. [17] Item 7, MD&A — Revenue by Payor and Significant States
  17. [18] Item 1, Business — Hospice
  18. [19] Item 7, MD&A — Results of Operations
  19. [20] Item 7, MD&A — Results of Operations
  20. [21] Item 7, MD&A — Hospice Segment
  21. [22] Item 7, MD&A — Hospice Segment
  22. [23] Item 1, Business — Home Health
  23. [24] Item 7, MD&A — Results of Operations
  24. [25] Item 7, MD&A — Results of Operations
  25. [26] Item 7, MD&A — Home Health Segment
  26. [27] Item 7, MD&A — Home Health Segment
  27. [28] Item 7, MD&A — Results of Operations
  28. [29] Item 7, MD&A — Results of Operations
  29. [30] Item 7, MD&A — Results of Operations
  30. [31] Item 7, MD&A — Results of Operations
  31. [32] Item 7, MD&A — Results of Operations
  32. [33] Item 7, MD&A — Results of Operations
  33. [34] Item 8, Financial Statements and Supplementary Data — Consolidated Statements of Income
  34. [35] Item 8, Financial Statements and Supplementary Data — Consolidated Statements of Income
  35. [36] Item 7, MD&A — Liquidity and Capital Resources
  36. [37] Item 7, MD&A — Liquidity and Capital Resources
  37. [38] Item 7, MD&A — Results of Operations
  38. [39] Item 7, MD&A — Results of Operations
  39. [40] Item 7, MD&A — Results of Operations
  40. [41] Item 7, MD&A — Results of Operations
  41. [42] Item 7, MD&A — Results of Operations
  42. [43] Item 7, MD&A — Results of Operations
  43. [44] Item 7, MD&A — Results of Operations
  44. [45] Item 7, MD&A — Results of Operations
  45. [46] Item 7, MD&A — Results of Operations
  46. [47] Item 7, MD&A — Results of Operations
  47. [48] Item 7, MD&A — Personal Care Segment
  48. [49] Item 7, MD&A — Personal Care Segment
  49. [50] Item 7, MD&A — Hospice Segment
  50. [51] Item 7, MD&A — Hospice Segment
  51. [52] Item 7, MD&A — Home Health Segment
  52. [53] Item 7, MD&A — Home Health Segment
  53. [54] Item 7, MD&A — Results of Operations
  54. [55] Item 7, MD&A — Results of Operations
  55. [56] Item 7, MD&A — Results of Operations
  56. [57] Item 7, MD&A — Results of Operations
  57. [58] Item 7, MD&A — Results of Operations
  58. [59] Item 7, MD&A — Results of Operations
  59. [60] Item 7, MD&A — Results of Operations
  60. [61] Item 7, MD&A — Results of Operations
  61. [62] Item 7, MD&A — Acquisitions
  62. [63] Item 1, Business — Our Growth Strategy
  63. [64] Item 7, MD&A — Divestiture
  64. [65] Item 7, MD&A — Divestiture
  65. [66] Item 1, Business — Our Growth Strategy
  66. [67] Item 1, Business — Our Growth Strategy
  67. [68] Item 1, Business — Our Growth Strategy
  68. [69] Item 1, Business — Our Growth Strategy
  69. [70] Item 1, Business — Our Growth Strategy
  70. [71] Item 1, Business — Our Growth Strategy
  71. [72] Item 1, Business — Our Growth Strategy
  72. [73] Item 1, Business — Our Growth Strategy
  73. [74] Item 7, MD&A — Changes in Illinois Reimbursement
  74. [75] Item 7, MD&A — Changes in Illinois Reimbursement
  75. [76] Item 7, MD&A — Changes in Illinois Reimbursement
  76. [77] Item 7, MD&A — Changes in Texas Reimbursement
  77. [78] Item 7, MD&A — Changes in Texas Reimbursement
  78. [79] Item 7, MD&A — Changes in Illinois Reimbursement
  79. [80] Item 7, MD&A — Changes in Medicare Reimbursement
  80. [81] Item 7, MD&A — Changes in Medicare Reimbursement
  81. [82] Item 7, MD&A — Changes in Medicare Reimbursement
  82. [83] Item 7, MD&A — Changes in Medicare Reimbursement
  83. [84] Item 7, MD&A — Changes in Medicare Reimbursement
  84. [85] Item 7, MD&A — Changes in Medicare Reimbursement
  85. [86] Item 7, MD&A — Changes in Medicare Reimbursement
  86. [87] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  87. [88] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  88. [89] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  89. [90] Item 7, MD&A — Liquidity and Capital Resources
  90. [91] Item 7, MD&A — Liquidity and Capital Resources
  91. [92] Item 7, MD&A — Liquidity and Capital Resources
  92. [93] Item 1A, Risk Factors — Our financial results have been, and may continue to be, adversely impacted by negative macroeconomic conditions.
  93. [94] Item 1A, Risk Factors — Our financial results have been, and may continue to be, adversely impacted by negative macroeconomic conditions.
  94. [95] Item 1A, Risk Factors — Our financial results have been, and may continue to be, adversely impacted by negative macroeconomic conditions.
  95. [96] Item 1A, Risk Factors — Reductions in reimbursement and other changes to Medicare, Medicaid, and other federal, state and local medical and social programs could adversely affect our consumer caseload, units of service, revenues, gross profit and profitability.
  96. [97] Item 7, MD&A — CMS Final Rule: “Ensuring Access to Medicaid Services”
  97. [98] Item 7, MD&A — CMS Final Rule: “Ensuring Access to Medicaid Services”
  98. [99] Item 1A, Risk Factors — Our financial results have been, and may continue to be, adversely impacted by negative macroeconomic conditions.
  99. [100] Item 1A, Risk Factors — Reductions in reimbursement and other changes to Medicare, Medicaid, and other federal, state and local medical and social programs could adversely affect our consumer caseload, units of service, revenues, gross profit and profitability.
  100. [101] Item 1A, Risk Factors — Our business may be adversely impacted by changes and uncertainty in the healthcare industry, including healthcare public policy developments and other changes to laws and regulations.
  101. [102] Item 1A, Risk Factors — Our business may be adversely impacted by changes and uncertainty in the healthcare industry, including healthcare public policy developments and other changes to laws and regulations.
  102. [103] Item 1A, Risk Factors — Our revenues are concentrated in a small number of states, which makes us particularly sensitive to regulatory and economic changes in those states.
  103. [104] Item 1A, Risk Factors — Future efforts to reduce the costs of the Illinois Department on Aging programs could adversely affect our service revenues and profitability.
  104. [105] Item 1A, Risk Factors — Our revenues are concentrated in a small number of states, which makes us particularly sensitive to regulatory and economic changes in those states.
  105. [106] Item 1A, Risk Factors — Our revenues are concentrated in a small number of states, which makes us particularly sensitive to regulatory and economic changes in those states.
  106. [107] Item 1A, Risk Factors — Our revenues are concentrated in a small number of states, which makes us particularly sensitive to regulatory and economic changes in those states.
  107. [108] Item 1A, Risk Factors — A cyber-attack or security breach could cause a loss of confidential consumer data, give rise to remediation and other expenses, expose us to liability under privacy laws, consumer protection laws, common law and other legal theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, result in interruptions or delays to services, adversely impact our financial results, and otherwise be disruptive to our business.
  108. [109] Item 1A, Risk Factors — We may be unable to pursue acquisitions or expand into new geographic regions without obtaining additional capital or consent from our lenders.
  109. [110] Item 1A, Risk Factors — We may be unable to pursue acquisitions or expand into new geographic regions without obtaining additional capital or consent from our lenders.
  110. [111] Item 1A, Risk Factors — We may be unable to pursue acquisitions or expand into new geographic regions without obtaining additional capital or consent from our lenders.
  111. [112] Item 5, Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
  112. [113] Item 1, Business — Our Growth Strategy
  113. [114] Item 1A, Risk Factors — We may not be able to attract and retain qualified personnel or we may incur increased costs in doing so.

Report on May 22, 2026